{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361418519257510912.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/sj.onc.1208500"}},{"identifier":{"@type":"URI","@value":"https://www.nature.com/articles/1208500.pdf"}},{"identifier":{"@type":"URI","@value":"https://www.nature.com/articles/1208500"}}],"dc:title":[{"@value":"Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381418519257510915","@type":"Researcher","foaf:name":[{"@value":"Hui Lin"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418519257511040","@type":"Researcher","foaf:name":[{"@value":"Giuseppe Monaco"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418519257510913","@type":"Researcher","foaf:name":[{"@value":"Tong Sun"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418519257510912","@type":"Researcher","foaf:name":[{"@value":"Clifton Stephens"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418519257510916","@type":"Researcher","foaf:name":[{"@value":"Shanhai Xie"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418519257510914","@type":"Researcher","foaf:name":[{"@value":"John Belmont"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418519257510918","@type":"Researcher","foaf:name":[{"@value":"Ralph Arlinghaus"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418519257510917","@type":"Researcher","foaf:name":[{"@value":"Xiaoyang Ling"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09509232"},{"@type":"EISSN","@value":"14765594"}],"prism:publicationName":[{"@value":"Oncogene"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2005-02-28","prism:volume":"24","prism:number":"20","prism:startingPage":"1","prism:endingPage":"11"},"reviewed":"false","dc:rights":["https://www.springer.com/tdm","https://www.springer.com/tdm"],"url":[{"@id":"https://www.nature.com/articles/1208500.pdf"},{"@id":"https://www.nature.com/articles/1208500"}],"createdAt":"2005-02-28","modifiedAt":"2022-03-22","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004236759920512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JAK2V617F+ myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640302097536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CCL2 is critical for immunosuppression to promote cancer metastasis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/sj.onc.1208500"},{"@type":"CROSSREF","@value":"10.1182/blood-2014-04-570572_references_DOI_42qZ2kVL6ImI4OyyJfk36V4PwRp"},{"@type":"CROSSREF","@value":"10.1007/s10585-012-9545-6_references_DOI_42qZ2kVL6ImI4OyyJfk36V4PwRp"}]}